Retention Is Your Real CAC Strategy: Email, SMS, and LTV Systems for Health Brands
Two supplement brands bid on the same Meta auction. Brand A breaks even at $45 CAC. Brand B breaks even at $110 because its average customer sticks around for seven orders instead of two. Brand B wins every auction that matters, scales into audiences Brand A can’t touch, and - from the outside - looks like it has a better ad account. It doesn’t. It has better retention.
This is the least glamorous truth in health growth: your allowable CAC is set in your lifecycle flows, not your ad manager. We spend most of our time on paid media, and we still tell founders the same thing - if your second-order rate is broken, no media buyer on earth can fix your unit economics.
Why does retention set your acquisition ceiling?
The math is short. Allowable CAC is a function of contribution margin per customer over the payback window you can finance. Raise LTV and you raise the ceiling on what you can pay for a customer - which means access to broader audiences, more aggressive scaling, and headroom to survive CPM spikes that kill thinner competitors. If you have not pinned the number down yet, start with patient acquisition cost.
Across partner accounts, health brands with a working retention system typically support an allowable CAC 1.5–2.5x higher than functionally identical brands selling one-and-done. That gap is the competitive moat, because in a Meta auction, the brand that can pay the most for a customer sets the price everyone else has to beat. The vertical-by-vertical numbers are in our CAC benchmarks, but the pattern holds everywhere: the ceiling belongs to whoever monetizes the customer longest.
Health is unusually well-suited to this game. Supplements, telehealth programs, and wellness products are inherently replenishable or ongoing - the product wants to be a subscription. Most brands just never build the system that makes it one.
What does a healthy subscription cohort actually look like?
A healthy cohort holds 75%+ through the first rebill and flattens by cycle 3 - the shape of the curve, not a blended “churn rate,” is what matters: what percentage of a monthly signup cohort is still active at each cycle.
| Cycle | Struggling account | Healthy account |
|---|---|---|
| Cycle 2 (first rebill) | 50–60% survive | 75%+ survive |
| Cycle 3 | steep continued drop | curve begins flattening |
| Cycle 6 | near zero | a stable core remains |
The diagnostic split that changes what you fix:
- Cycle-2 cliff → an acquisition problem wearing a retention costume. Discount-hunters, mismatched expectations from the ad, or a subscription default the buyer didn’t notice. Fix the offer and the ad-to-lander promise, not the email flows.
- Slow bleed from cycle 3 on → a genuine retention problem. The product isn’t visibly working, the routine didn’t form, or nobody’s reinforcing why to stay.
For health products the second failure mode has a specific cause: most health outcomes are felt slowly. A customer three weeks into a supplement often can’t tell if it’s “working.” If nothing bridges that perception gap - usage guidance, what-to-expect timelines, habit reinforcement - the cancel is rational. Your onboarding flow’s real job is managing expectations across the first 60 days, not cross-selling.
Which email and SMS flows actually move LTV?
Five flows move LTV: onboarding, pre-rebill notices, cancel-intercepts, win-backs, and replenishment reminders. Most health brands have a welcome series and a campaign calendar instead - which is to say they have nothing. In order of impact we see across AdBoost Health partner accounts:
- Post-purchase onboarding (days 0–30). What to expect, how to take it, when most people notice a difference. This is the highest-leverage flow in a health account because it directly attacks the “is it working?” cancel.
- Pre-rebill notice with an off-ramp menu. Counterintuitive, but warning customers before the charge - with options to delay, downsize, or swap instead of cancel - reduces both churn and chargebacks. A skipped month is a retained customer; a surprise charge is a refund and a lost one.
- Cancel-intercept flows. Reason-specific saves: “too much product piling up” gets a frequency change, “too expensive” gets a smaller size, “not sure it’s working” gets the expectation-setting content they missed. One generic 20%-off save offer trains customers to cancel for discounts.
- Win-back (30/60/90 days post-churn). Sequenced by churn reason, not blasted. Recently lapsed customers respond to “pick up where you left off”; long-lapsed ones need a new angle entirely - new formulation, new format, new problem. Win-backs are the cheapest “acquisition” channel you have: the trust is already built.
- Replenishment reminders for non-subscribers. Timed to actual consumption. This is the single most reliable path from one-time buyer to subscriber, because it catches the customer at the exact moment the product proved itself.
SMS earns its place in exactly two of these: rebill notices and replenishment nudges - time-sensitive, transactional, high-consent. Health brands that push claims-heavy promotional SMS burn the channel fast, and carriers filter health-adjacent messaging aggressively.
How do you keep lifecycle messaging compliant?
Apply the same claim discipline to flows that you apply to ads. Email and SMS feel private, but the FTC reads them the same way it reads your landing page - and structure/function rules don’t have a “but it was just a newsletter” exemption.
- Same claim language everywhere. “Supports,” “helps maintain,” “promotes” - the hedged claim architecture from your ad creative system is the same one your flows should inherit. If the ad can’t say “fixes your gut,” the day-14 email can’t either.
- Testimonials in flows need the same substantiation as testimonials in ads. Customer quotes claiming disease outcomes (“cured my insomnia”) can’t be forwarded to your list just because a customer said them.
- Telehealth adds HIPAA gravity. Anything implying a person’s condition or treatment status in an email subject line or SMS preview is a privacy problem, not just a marketing one. Lifecycle segmentation by condition requires real consent architecture - build it with counsel, not with a Klaviyo tag.
Where should a founder start?
Not with more campaigns. Pull your cohort curves first - if you can’t produce a cycle-by-cycle retention table for last quarter’s signups in ten minutes, that’s the whole to-do list right there. Then fix in order: the cycle-2 cliff (offer and expectations), onboarding, cancel-intercept, win-back. Each fix compounds the value of every ad dollar you’re already spending - the same offer-architecture logic we walk through in the supplement CAC playbook.
We’re a paid-media agency that audits retention on every account we take, because scaling spend into a leaky bucket is how founders end up blaming the ads for a subscription problem. If you want the cohort math done on your account - allowable CAC included - book a free 30-minute strategy call and we’ll send you the written plan whether or not we work together.
